Localized scleroderma, as the term denotes, is localized to the skin on the hands and face. It is characterized by slow progression and rarely transforms to the systemic type. Localized scleroderma is ...

Scleroderma diagnosis is rather difficult as the symptoms of the disease overlap with those of other conditions. Therefore, it becomes necessary to rule out other auto immune diseases before focusing ...

What is the latest research on scleroderma? Find out in this collection of recent MEDLINE abstracts compiled by the editors at Medscape Nurses. Acute and chronic renal diseases remain common ...

The Global Localized Scleroderma Market is expected to reach at a Significant CAGR during the forecast period 2024-2031. The Localized Scleroderma Market is driven by rising autoimmune disease ...

Durham, NC - A study released today in STEM CELLS Translational Medicine suggests a new way to correct facial atrophy of localized scleroderma (LoS) in patients. It shows how applying grafts made up ...

A reader writes in to note that June is scleroderma month and points out that more Canadians have this disease than those with cystic fibrosis, multiple sclerosis or muscular dystrophy combined. She ...

Fibrocell Science, a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, announced the submission of an Investigational New Drug ...

Read full article: ‘It’s a blessing’: Long lines reflect deep need as Forgotten Harvest distributes food in Detroit File photo of woman welding (AP Photo/John Amis) -- The Michigan Skilled Careers Job ...

DelveInsight’s ‘Scleroderma Pipeline Insights’ report lays down a holistic coverage of the available therapies, Scleroderma pipeline therapies in different developmental phases of clinical trials, key ...

Dublin, Sept. 29, 2023 (GLOBE NEWSWIRE) -- The "Scleroderma Diagnostics and Therapeutics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global ...

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Scleroderma pipeline constitutes 45+ key companies continuously working towards developing 50+ Scleroderma treatment ...